Silk Road Medical, Inc (2OW.SG)

17,90 +0,80 (+4,68%) Börsenschluss: 09:54PM CEST

Silk Road Medical, Inc

1213 Innsbruck Drive
Sunnyvale, CA 94089
United States
408 720 9002
https://silkroadmed.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 474

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Charles S. McKhann	CEO & Director	280,7k	N/A	1969
Mr. Lucas W. Buchanan	CFO & COO	781k	3,78M	1978
Mr. Kevin M. Klemz	EVP, Chief Legal Officer & Secretary	620,92k	N/A	1961
Mr. Andrew S. Davis	Chief Commercial Officer	1,12M	1,36M	1969
Mr. Richard M. Ruedy	Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance	444,48k	N/A	1967
Ms. Mhairi L. Jones	Chief Accounting Officer & VP of Finance	N/A	N/A	1971
Ms. Tammy Leitsinger	Compliance Officer & VP of Medical Affairs	N/A	N/A	N/A
Mr. Jorge O'Hara	Vice President of Marketing, Business Development & Strategy	N/A	N/A	N/A
Ms. Alison Highlander	Vice President of Human Resources	N/A	N/A	N/A
Dr. Sumaira MacDonald M.D., Ph.D.	Executive Medical Director	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Corporate Governance

Silk Road Medical, Incs ISS Governance QualityScore, Stand 29. April 2024, lautet 9. Die grundlegenden Scores sind Audit: 8, Vorstand: 4, Shareholderrechte: 7, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.